Ambio will test ibogaine, an experimental, naturally occurring psychedelic, as a therapy for neurodegenerative conditions such as MS.

Helius Medical Technologies calls the out-of-network reimbursement the first step in making the PoNS device more accessible to MS patients.

Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of ...

Dr. Susan Payrovi and Dr. Mirla Avila have an in-depth discussion around treating MS, and considerations when selecting an MS treatment.

Task-oriented training may help balance issues for people with MS, but current evidence is inconsistent, a study found.

A study of 125 children with POMS and 145 without major health disorders found that epigenetic age tended to be higher in children with POMS.

If a routine streamlined a process and passed the common sense test, I was more than happy to adopt it. However, if it caused more harm than good, I took great pride in being able to adapt quickly. In ...

Infections and stressful life events in childhood may increase the risk of developing MS, according to a study.

Four Canadian nurses are among the 11 recipients of this year's International Nightingale Awards, which support innovative ...

Ocrevus appears to be a safe and effective treatment for children and adolescents with MS, according to real-world data from ...

Body mass index (BMI) does not seem to affect responses to stem cell transplant in people with MS, a study found.

MS prevalence has increased by about one-third in New Zealand in recent decades, though some barriers to diagnosis still ...